Switch to
More onapp

F D C Ltd

FDC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,797 cr, stock is ranked 530
Low RiskStock is 1.68x as volatile as Nifty
286.901.85 (+0.65%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,797 cr, stock is ranked 530
Low RiskStock is 1.68x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
22.17
PB RatioPB Ratio
2.45
Dividend YieldDiv. Yield
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

Brands

F D C

Pharmaceutical company

Electral

Oral rehydration powder

Investor PresentationView older 

Nov 14, 2022

PDF
View Older Presentations

Brands

F D C

Pharmaceutical company

Electral

Oral rehydration powder

Financial TrendFinancial statements 

20192020202120221.131.411.431.600.170.240.300.22
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

General updates 
Announced OnNov 24, 2022

FDC Limited has informed the Exchange about FDC Limited¬タルs Brand ZIFI and FAVENZA awarded at AWACS 2022. | Download

FDC Limited has informed the Exchange about FDC Limited¬タルs Brand ZIFI and FAVENZA awarded at AWACS 2022. | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 19, 2022

FDC Limited has informed the Exchange about Transcript (Typo corrections) of Analysts/Institutional Investor Meet/Con. Call | Download

FDC Limited has informed the Exchange about Transcript (Typo corrections) of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateMar 19, 2020

Interim • Div/Share: ₹ 0.8

See all events